icer John Young; Moderna President Stephen Hoge; Johnson & Johnson Janssen Pharmaceutical Companies Medical Affairs Vice President Richard Nettles; AstraZeneca BioPharmaceuticals Business Unit President and Executive Vice President Ruud Dobber; and Novavax Executive Vice President, Chief Commercial Officer, and Chief Business Officer John